The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

Abstract Background/Objectives Immune checkpoint inhibitors are frequently used to treat advanced non-small cell lung cancer (NSCLC). Drug clearance also varies depending on patient-related factors. Therefore, the lung immune prognostic index (LIPI), based on inflammatory markers, may help predict p...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz, Mevlude Inanc, Metin Ozkan, Emel Mutlu Ozkan, Deniz Can Guven, Mustafa Erman, Latif Karahan, Elif Sahin, Anıl Karakayali, Pervin Can Sanci, Umut Kefeli, Devrim Cabuk, Erdem Kolemen, Mehmet Mutlu Kidi, Sedat Biter, Tolga Koseci, Muslih Urun, Berrak Mermit Ercek, Duygu Bayir, Gözde Agdas, Teoman Sakalar, Nargiz Majidova, Sedat Yildiz, Hacer Demir, Cengiz Akosman, Mustafa Ersoy, Saadettin Kilickap, Erkam Kocaaslan, Ezgi Turkoğlu, Sedat Yildirim, Hayati Arvas, Havva Yesil Cinkir, Aslihan Ezgi Apaydin Rollas
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Springer 2026-02-01
Sraith:	Discover Oncology
Ábhair:	Non-small cell lung cancer Lung immune prognostic index Nivolumab Survival Lung immune prognostic index changes
Rochtain ar líne:	https://doi.org/10.1007/s12672-026-04705-x
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

Míreanna comhchosúla